Torthaí cuardaigh - Luís Querol

Beachtaigh na torthaí
  1. 1
    Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP

    Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP de réir Luís Querol, Cinta Lleixà

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity

    A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of... de réir Mariana López‐Góngora, Luís Querol, Antonio Escartín

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Antibodies in Autoimmune Neuropathies

    Antibodies in Autoimmune Neuropathies de réir Elba Pascual‐Goñi, Marta Caballero‐Ávila, Luís Querol

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects

    Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects de réir Constance Manso, Luís Querol, Mourad Mekaouche, Isabel Illa, Jérôme Devaux

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy

    Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy de réir Filip Eftimov, Ilse M. Lucke, Luís Querol, Yusuf A. Rajabally, Camiel Verhamme

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Specific Contactin N-Glycans Are Implicated in Neurofascin Binding and Autoimmune Targeting in Peripheral Neuropathies

    Specific Contactin N-Glycans Are Implicated in Neurofascin Binding and Autoimmune Targeting in Peripheral Neuropathies de réir Marilyne Labasque, Bruno Hivert, Gisela Nogales‐Gadea, Luís Querol, Isabel Illa, Catherine Faivre‐Sarrailh

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)

    Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP) de réir Luís Querol, Madeleine Crabtree, M. Herepath, E. Priedane, I. Viejo Viejo, S. Agush, P. Sommerer

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Anti–neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo

    Anti–neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo de réir Constance Manso, Luís Querol, Cinta Lleixà, Mallory Poncelet, Mourad Mekaouche, Jean‐Michel Vallat, Isabel Illa, Jérôme Devaux

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

    Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin de réir Elena Cortés‐Vicente, Eduard Gallardo, María Ángeles Martínez, Jordi Díaz‐Manera, Luís Querol, Ricard Rojas‐García, Isabel Illa

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    COVID-19-associated ophthalmoparesis and hypothalamic involvement

    COVID-19-associated ophthalmoparesis and hypothalamic involvement de réir Elba Pascual‐Goñi, Juan Fortea, Alejandro Martínez‐Domeño, Núria Rabella, Mario Tecame, Cristina Gómez-Oliva, Luís Querol, Beatriz Gómez‐Ansón

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies

    Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies de réir Min Xu, David Bennett, Luís Querol, Long‐Jun Wu, Sarosh R. Irani, James C. Watson, Sean J. Pittock, Christopher J. Klein

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations

    COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations de réir Michael P. Lunn, David R. Cornblath, Bart C. Jacobs, Luís Querol, P.A. van Doorn, Richard AC Hughes, Hugh J. Willison

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies

    The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies de réir Luís Querol, Hans‐Peter Hartung, Richard A. Lewis, Pieter A. van Doorn, Timothy R. Hammond, Nazem Atassi, Miguel Alonso‐Alonso, Marinos C. Dalakas

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients

    Analysis of Serum miRNA Profiles of Myasthenia Gravis Patients de réir Gisela Nogales‐Gadea, Alba Ramos‐Fransí, Xavier Suárez‐Calvet, Miquel Navas‐Madroñal, Ricard Rojas‐García, José Luis Mosquera, Jordi Díaz‐Manera, Luís Querol, Eduard Gallardo, Isabel Illa

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy

    Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy de réir Émilien Delmont, Constance Manso, Luís Querol, Andrea Cortese, Angela Berardinelli, Alessandro Lozza, Maya Belghazi, Pauline Malissart, Pierre Labauge, Guillaume Taïeb, Nobuhiro Yuki, Isabel Illa, Shahram Attarian, Jérôme Devaux

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg

    Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg de réir Luís Querol, Gisela Nogales‐Gadea, Ricardo Rojas‐García, Jordi Díaz‐Manera, Julio Pardo, A Ortega-Moreno, María J. Sedano, Eduard Gallardo, José Berciano, Rafael Blesa, Josep Dalmau, Isabel Illa

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins

    Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins de réir Luís Querol, Ricard Rojas‐García, Jordi Díaz‐Manera, Joseba Bárcena, Julio Pardo, A Ortega-Moreno, María J. Sedano, Laia Seró-Ballesteros, Alejandra Carvajal, Nicolau Ortiz, Eduard Gallardo, Isabel Illa

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study

    Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, pl... de réir Luís Querol, de Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao, Michael H. Rivner, Hans‐Peter Hartung, Peter Kießling, Saori Shimizu, Dominika Marmol, Ali Bozorg, Anny‐Odile Colson, Ute Massow, Filip Eftimov

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy

    Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy de réir Luís Querol, Ana M. Siles, Roser Alba-Rovira, Agustín Jáuregui, Jérôme Devaux, Catherine Faivre‐Sarrailh, Josefa Araque, Ricard Rojas‐García, Jordi Díaz‐Manera, Elena Cortés‐Vicente, Gisela Nogales‐Gadea, Miquel Navas‐Madroñal, Eduard Gallardo, Isabel Illa

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis

    The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis de réir Elena Cortés‐Vicente, Ricard Rojas‐García, Jordi Díaz‐Manera, Luís Querol, Carlos Casasnovas, A. Guerrero-Solá, José Luís Muñoz-Blanco, José Eulalio Bárcena, C. Márquez Infante, Julio Pardo, E Martínez-Fernández, Mercedes Usón, Pedro Oliva‐Nacarino, Teresa Sevilla, Isabel Illa

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: